Ningxia Kunzheng Biotechnology Co., Ltd. is a new comprehensive pharmaceutical manufacturing enterprise that integrates the production and sale of pharmaceutical intermediates, raw materials, and chemical products. The company is located in the south of Ankang Street, east of Suning Avenue, Taiyangshan Development Zone, Wuzhong City, Ningxia Hui Autonomous Region, China, with a total area of 300 mu. The company has invested more than 600 million yuan to build a project with an annual output of 3000 tons of L-carnitine and its salts and a project with an annual output of 5000 tons of fluorobenzene medicine, which will be put into operation at the end of 2021. After full production, it will become the largest manufacturer of L-carnitine projects in the world and one of the largest manufacturers of fluorobenzene pharmaceutical projects in China, with an annual output value of more than 1.2 billion yuan.

L-carnitine products are widely used in health care, milk powder, functional drinks, food additives, and other related fields, and its market is mainly distributed in the United States, Britain, Germany, India, Japan, and other countries.

Fluorobenzene project products are the necessary raw materials for the fluoro-chemical industry, which are widely used in medicine, new energy, new materials, aerospace, and other related fields, and its market is all over the world.